Requires the Comptroller General to assess wearable medical devices' use in clinical decision-making, focusing on their treatment-prescribing accuracy, AI's role in enhancing capabilities, and policy options to optimize benefits and address development challenges.
Mandates the Comptroller General to conduct a technology assessment of wearable medical devices within 18 months of the Act's enactment.
Requires submission of a report to Congress on the capabilities and limitations of these devices in supporting clinical decision-making.
Includes a description of the potential for wearable devices to accurately prescribe treatments.
Examines the benefits and challenges of using artificial intelligence to augment these capabilities.
Suggests policy options to enhance the benefits and address the challenges of developing or using wearable medical devices.
This machine-generated summary is awaiting review by an AGORA editor. Use with caution.
Key facts
🏛️ This document was proposed and/or enacted by the United States Congress but is now defunct.
For authoritative text and metadata, visit the official source.
📜 This document's name is Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act 2025 (Section 217 "Report on Wearable Medical Devices").
AGORA also tracks this document under the name Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act ("Report on Wearable Medical Devices"). It is part of Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act 2025.
Themes AI risks, applications, governance strategies, and other themes addressed in AGORA documents.
Thematic tags are in progress.
Full text
This is an unofficial copy. The document has been
archived and reformatted in plaintext for AGORA. Footnotes, tables, and
similar material may be omitted. For the official text, visit the original source.
SEC. 217. REPORT ON WEARABLE MEDICAL DEVICES.
Not later than 18 months after the date of the enactment of this
Act, the Comptroller General of the United States shall conduct a
technology assessment of, and submit to Congress a report on, the
capabilities and limitations of wearable medical devices used to
support clinical decision-making. Such report shall include a
description of--
(1) the potential for such devices to accurately prescribe
treatments;
(2) an examination of the benefits and challenges of
artificial intelligence to augment such capabilities; and
(3) policy options to enhance the benefits and mitigate
potential challenges of developing or using such devices.
Requires the Comptroller General to report on wearable medical devices' capabilities and AI augmentation benefits.
Requires the Comptroller General to report on wearable medical devices' capabilities and AI augmentation benefits.